Bausch + Lomb Corporation BLCO

Updated: 8 Sep 2026

NYSE | Biotech | Eye health and medical devices

No signal published yet

We already track Bausch + Lomb and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Bausch + Lomb free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NYSE
Type
Biotech
Sector
Eye health and medical devices
We're already tracking Bausch + Lomb Corporation — here are the latest events we've registered

Recent News

  • On August 24, 2026, Bausch + Lomb announced that two of its eye health drug candidates will advance into expanded clinical trials following positive study results. The pipeline developments include moving a dual-action dry eye drop candidate into Phase 3 trials and advancing its ocular surface pain candidate BL1332.

What Firelda Watch includes for Bausch + Lomb Corporation

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Bausch + Lomb Corporation will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Getinge
GETI B
HOLD
Surgical Science Sweden AB (publ)
SUS
HOLD
Vitrolife AB (publ)
VITR
HOLD
Vimian Group AB (publ)
VIMIAN
HOLD
CellaVision AB (publ)
CEVI
HOLD

Biotech

More companies in this sector

Want to follow Bausch + Lomb Corporation? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Bausch + Lomb free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Bausch + Lomb Corporation BLCO
Bausch + Lomb — follow and we'll monitor it
Follow Bausch + Lomb free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.